Company Versartis Inc Nasdaq
Equities
US92529L1026
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Leonard Dove
COO | Chief Operating Officer | 51 | 20/03/22 |
Gail McIntyre
BRD | Director/Board Member | 61 | 30/09/18 |
Marek Ciszewski
IRC | Investor Relations Contact | - | - |
Maria Petrini
PRN | Corporate Officer/Principal | - | 09/04/23 |
Jody Gould
LAW | General Counsel | - | 31/01/21 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Gail McIntyre
BRD | Director/Board Member | 61 | 30/09/18 |
Fred Eshelman
CHM | Chairman | 76 | 07/04/20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 73,562,648 | 45,102,753 ( 61.31 %) | 0 | 61.31 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |